Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epigenetic silencing of triple negative breast cancer hallmarks by Withaferin A

13 Apr 2017

Abstract excerpt

// Katarzyna Szarc vel Szic 1, 4 , Ken Declerck 1 , René A.J. Crans 1, 3 , Jolien Diddens 1 , David B. Scherf 2 , Clarissa Gerhäuser 2 and Wim Vanden Berghe 1 1 Laboratory of Protein Chemistry, Proteomics and Epigenetic Signaling (PPES), Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium 2 Workgroup Cancer Chemoprevention and Epigenomics, Division of Epigenomics and Cancer Risk...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to PARP inhibition in cancer therapy
Share to Phytochemicals and Medicinal Plants

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28467815
DOI: 10.18632/oncotarget.17107

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epigenetic silencing of triple negative breast cancer hallmarks by Withaferin APMID 28467815Read ↗

p21 Promoter Methylation Is Vital for the Anticancer Activity of Withaferin ASemantic proximity Read ↗

Epi-drugs as triple-negative breast cancer treatmentSemantic proximity Read ↗

A Novel Combination of Withaferin A and Sulforaphane Inhibits Epigenetic Machinery, Cellular Viability and Induces Apoptosis of Breast Cancer CellsSemantic proximity Read ↗

Epigenetics of Triple-Negative Breast Cancer via Natural CompoundsSemantic proximity Read ↗

Combinatorial phenethyl isothiocyanate and withaferin A targets multiple epigenetics pathways to inhibit MCF-7 and MDA-MB-231 human breast cancer cellsSemantic proximity Read ↗

RNA‐seq reveals novel cancer‐selective and disease subtype‐independent mechanistic targets of withaferin A in human breast cancer cellsSemantic proximity Read ↗

Retinoic Acid Sensitivity of Triple-Negative Breast-Cancer Cells Characterized by Constitutive Activation of the NOTCH1 Pathway: The Role of RARβSemantic proximity Read ↗

Withaferin-A kills cancer cells with and without telomerase: chemical, computational and experimental evidences.Semantic proximity Read ↗

Integrated Epigenetics of Human Breast Cancer: Synoptic Investigation of Targeted Genes, MicroRNAs and Proteins upon Demethylation TreatmentSemantic proximity Read ↗

ADAM12 is A Potential Therapeutic Target Regulated by Hypomethylation in Triple-Negative Breast CancerSemantic proximity Read ↗

Withaferin A mediated changes of miRNA expression in breast cancer‐derived mammospheresSemantic proximity Read ↗

Targeting DNA Methylation for Treating Triple-Negative Breast CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.